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Abstract
Human brucellosis is mainly caused by contact with Brucel-
la-infected animals and their secretions and carcasses. Individuals
who are continuously in contact with animals are considered to be
at a high risk but only some show symptoms and are diagnosed as
cases of brucellosis. Here, we showed that asymptomatic brucel-
losis infections occur among humans. Asymptomatic infections
mainly result from less frequent contact with Brucella and/or
contact with low-virulence Brucella. In our study, patients with
asymptomatic infection had low antibody titres and different
contact patterns. Awareness of asymptomatic infection is impor-
tant for early diagnosis of brucellosis and prevention of chronic
infection.
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Brucellosis is a common zoonosis caused by Brucella spp. In
humans, it is caused by ingestion of raw dairy products,
consumption of infected meat from domestic livestock, and
close contact with their secretions and carcasses [1]. High
fever, myalgia and arthralgia of the large joints are the main
symptoms. In brucellosis-endemic areas, individuals who are
continuously in contact with animals are at a high risk of
becoming infected [2]. However, only some manifest clinical
symptoms, visit clinics and are diagnosed with brucellosis. In
cases of infectious disease, the absence of clinical symptoms
can be due to either true non-carrier status or asymptomatic
infection [3]. In asymptomatic infection and subclinical infec-
tion, individuals carry the disease without symptoms, but will
be symptomatic under some conditions, such as decline in
immune status or re-infection. Awareness of asymptomatic
infection is important for timely diagnosis and effective
treatment of infectious diseases. Asymptomatic infection was
observed in occasionally infected patients [4]. However, it is
not known whether some high-risk individuals without clinical
symptoms of brucellosis are actually infected, and this needs to
be established.
To test the possibility of asymptomatic brucellosis infection
in humans, we ﬁrstly recruited high-risk individuals from Jilin
Province, a region of endemic human brucellosis infection in
China [5]. The participants all had a history of continuous
contact with animals and/or their products, had not been
immunized with Brucella vaccines previously, and did not show
the typical symptoms (continuous fever, sweating, fatigue and
arthralgia) of brucellosis. Serum samples were collected and
tested for Brucella antibodies using the Standard Agglutination
Test (SAT). Serum samples were diluted at 1:50, 1:100 and
1:200 and tested with SAT. SAT titres  1:100 were deﬁned as
positive. The results showed that approximately 45% (135 of
300) of individuals tested positive for Brucella antibodies. To
further test the existence of Brucella, blood samples were
collected from antibody-positive participants and Brucella DNA
was detected by an in-house real-time PCR (forward primer,
GCCAATGCCATTGCCAAG; reverse primer, GTTCACT
GATTTCCACCACAC; Taqman probe, FAM-AAGACGC
TTGCCGACGCTGC-TAMRA) developed essentially as
described previously [6,7]. The real-time PCR showed a
sensitivity of 10 copies per reaction. Brucella DNA was
detected in 25% (25 of 100) of the blood samples. These data
implied that asymptomatic infection exists in high-risk individ-
uals. In practice, we have found that some patients with a long
history of animal contact had chronic infection when
diagnosed. Long-term treatment is necessary for these patients
[8]. The presence of Brucella DNA in blood samples of these
patients implied that they were in active infection or recovery
stages. This was observed in a previous study, which found that
Brucella DNA could be detected from months to 2 years after
recovery from symptoms [9].
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Next, information on asymptomatic and symptomatic
individuals was collected and analyzed to further characterize
asymptomatic infection and differentiate it from symptomatic
infection. As shown in Table 1, symptomatic patients mainly
had the following clinical symptoms: fever (78.0%), sweating
(41.3%), weakness (37.7%) and headache (26.1%). Symptomatic
patients usually had more than one typical symptom. In the
asymptomatic group, all the individuals showed none of the
symptoms. More men were symptomatic than women, and
symptomatic patients were older than asymptomatic patients,
but this latter result was not signiﬁcant. For these symptomatic
patients, the average duration from ﬁrst appearance to
diagnosis was 62.3 (95% CI, 47.8–76.8) days. Antibody titres
were tested by SAT and compared between the two groups.
The titres of asymptomatic patients were signiﬁcantly lower
than those of symptomatic patients (116.7 vs. 143.5, p <0.05).
A high proportion of the asymptomatic patients had SAT titres
of 1:100, indicating that asymptomatic infection patients had
low antibody titers. This lower antibody titre in asymptomatic
patients might result from lower frequency or longer duration
of infection.
Animal contact is the main risk factor for human brucellosis
[10]. Asymptomatic patients had a slightly lower frequency of
sheep contact but higher frequencies of cattle contact (15.9%
vs. 8.3%, p 0.013) and pig contact (19.2% vs. 8.5%, p 0.001)
than symptomatic patients. No signiﬁcant differences were
observed in contact frequencies with goats, dogs or deer,
which seems to be consistent with the different virulence of
various Brucella species epidemic in this region. According to
host preference, Brucella is conventionally divided into six
different species, including Brucella melitensis (sheep), B. abortus
(cattle), B. canis (dogs), B. suis (pigs), B. ovis (goats) and
B. neotome (desert and wood rats) [11]. Four of these species
are pathogenic in humans, with B. melitensis being the most
virulent species, followed by B. abortus, B. suis and B. canis. In
Jilin province, the most predominant Brucella species are
B. melitensis followed by B. abortus, and other species are
seldom identiﬁed. Therefore, the differential animal contact
frequencies between participants with asymptomatic infection
and those with symptomatic infection are consistent with the
fact that B. abortus (cattle) and B. suis (pig) have lower
virulence in humans than B. melitensis (sheep) [12].
We also compared the manner of contact between
participants with asymptomatic infection and those with
symptomatic infection. It is known that the main means of
contact are skin, fur, secretions and carcasses [13]. Interest-
ingly, there were no signiﬁcant differences between the two
groups regarding contact with skin, fur, dairy or abor-
tion-related products. However, patients with symptomatic
infection had higher contact frequencies with contaminated
soil and animal faeces (Table 1). As Brucella exists in high
quantities in these environments [14], the higher frequency of
contact with these substances may have resulted in symptom-
atic infection. This is instructive for prevention of Brucella
infection: in addition to avoiding conventional risk factors,
high-risk persons should also avoid contact with soil, faeces
and dust contaminated by animals.
In this study, we conﬁrmed that asymptomatic brucellosis
infection occurs in some individuals. Asymptomatic infection
may result from contact with animals harbouring lower-viru-
lence species of Brucella or from less frequent contact with
contaminated soil, faeces and dust. Symptomatic infections
were due to frequent contact with contaminated faeces, soil
and dust, where the pathogen persists for a long period [10].
Highly frequent exposure to these contaminated environments
might lead to higher infection load of Brucella and cause the
symptomatic infection. Identiﬁcation of individuals with asymp-
tomatic brucellosis is important for its early diagnosis,
prevention of chronic infection, and tracking of disease
prevalence. Awareness of the different clinical symptoms
found in symptomatic infections is important for early
diagnosis. Individuals in endemic areas who have a history of
contact with potentially infected animals and their products
and environments should be alerted to the risk of asymptom-
atic Brucella infection in humans when there is a sudden
increase in incidence [15]. Asymptomatic infection is of great
TABLE 1. Comparison of asymptomatic and symptomatic
infection
Variables
Asymptomatic
(n = 131)
Symptomatic
(n = 506) p value (95% CI)
Demographics
Male 97 (74.0%) 395 (77.4%) 0.355 (0.346–0.365)
Age 41.85
(39.48–44.22)
42.84
(41.62–44.05)
0.365
(0.294–0.398)
Contact animal
Sheep 53 (42.4%) 243 (48.2%) 0.273 (0.264–0.281)
Goat 3 (2.4%) 11 (2.2%) 1.000 (1.000–1.000)
Pig 24 (19.2%) 43 (8.5%) 0.001 (0.001–0.002)
Dog 39 (31.2%) 123 (24.4%) 0.139 (0.132–0.145)
Deer 2 (1.6%) 3 (0.6%) 0.261 (0.2524–0.269)
Cold Sheep 33 (26.4%) 155 (30.8%) 0.385 (0.375–0.394)
Cattle 20 (15.9%) 42 (8.3%) 0.013 (0.011–0.016)
Contact manner
Skin 103 (78.6%) 395 (78.1%) 0.904 (0.898–0.909)
Fur 82 (62.6%) 357 (70.6%) 0.087 (0.082–0.093)
Abortion 53 (40.5%) 263 (52.0%) 0.023 (0.020–0.026)
Dust 6 (4.6%) 99 (19.6%) 0.000 (0.000–0.000)
Soil 4 (3.1%) 82 (16.2%) 0.000 (0.000–0.000)
Faeces 4 (3.1%) 78 (15.4%) 0.000 (0.000–0.000)
Digestive tract 1 (0.8%) 2 (0.4%) 1.000 (1.000–1.000)
Dairy 2 (1.5%) 10 (2.0%) 1.000 (1.000–1.000)
Symptoms
Fever 0 (0.0%) 394 (78.0%) 0.000 (0.000–0.000)
Sweating 0 (0.0%) 209 (41.3%) 0.000 (0.000–0.000)
Fatigue 0 (0.0%) 191 (37.7%) 0.000 (0.000–0.000)
Headache 0 (0.0%) 132 (26.1%) 0.000 (0.000–0.000)
Knee ache 0 (0.0%) 68 (13.4%) 0.000 (0.000–0.000)
Backache 0 (0.0%) 111 (21.9%) 0.000 (0.000–0.000)
Arthralgia 0 (0.0%) 114 (22.5%) 0.000 (0.000–0.000)
Testicular pain 0 (0.0%) 21 (4.2%) 0.022 (0.019–0.025)
Muscle pain 0 (0.0%) 17 (3.4%) 0.058 (0.054–0.063)
Shoulder ache 0 (0.0%) 21 (4.2%) 0.022 (0.019–0.025)
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value for early diagnosis of brucellosis in non-endemic areas.
Clinicians should take into consideration the exposure of
individual patients and the possibility of asymptomatic infection
with Brucella.
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